Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 AUD | +6.45% | +38.66% | +96.43% |
03-26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
03-18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Tillett
CEO | Chief Executive Officer | - | 11-21 |
Chief Tech/Sci/R&D Officer | - | 30/06/23 | |
Tim Hammond
CTO | Chief Tech/Sci/R&D Officer | - | 22/03/23 |
Michael Kelso
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/21 |
Chief Tech/Sci/R&D Officer | - | 29/02/20 | |
Phillip Lynch
BRD | Director/Board Member | - | 31/05/20 |
Sophia Moscovis
PRN | Corporate Officer/Principal | - | - |
Borje Andersson
PRN | Corporate Officer/Principal | - | 31/01/20 |
Peter Webse
SEC | Corporate Secretary | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Smith
BRD | Director/Board Member | 61 | 28/06/23 |
Borje Andersson
PRN | Corporate Officer/Principal | - | 31/01/20 |
Phillip Lynch
BRD | Director/Board Member | - | 31/05/20 |
Mary Harney
CHM | Chairman | - | 07/02/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 163,496,251 | 121,078,645 ( 74.06 %) | 0 | 74.06 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+96.43% | 170M | |
+4.03% | 111B | |
+11.43% | 105B | |
-12.65% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.47% | 13.7B | |
+36.22% | 12.45B |
- Stock Market
- Equities
- RAC Stock
- Company Race Oncology Limited